Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Rare Biomarkers Specimen Collection And Stabilization Global Market Report 2025
Request Sample Buy Now
Global Rare Biomarkers Specimen Collection And Stabilization Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Rare Biomarkers Specimen Collection And Stabilization Global Market Report 2025

By Type (Circulating Cell Free Deoxyribonucleic Acid (CCFDNA), Circulating Tumor Cells (CTCs), Exosomes or Extracellular Vesicles), By Specimen (Serum Or Plasma, Other Specimens), By Application (Non-Invasive Prenatal Testing (NIPT), Oncology, Transcriptomics, Pharmacogenomics, Transplant Rejection, Population Screening, Cardiovascular Diseases, Other Applications), By End-User (Hospitals, Perinatal Clinics, Public Health Labs, Private Or Commercial Labs, Physician Labs, Research Institutes, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Rare Biomarkers Specimen Collection And Stabilization Market Overview

• Rare Biomarkers Specimen Collection And Stabilization market size has reached to $32.01 billion in 2024

• Expected to grow to $51.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%

• Growth Driver: Increasing Prevalence Of Cancer Is Driving The Growth Of The Rare Bio Markers Specimen Collection And Stabilization

• Market Trend: Innovative Automated Pre-Analytical Platform Revolutionizes Biomarker Specimen Collection And Stabilization

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Rare Biomarkers Specimen Collection And Stabilization Market?

Rare biomarkers specimen collection and stabilization refers to the process of collecting and preserving biological samples containing rare or low-abundance molecules that serve as indications of specific biological processes, diseases, or situations. These biomarkers could be specific proteins, nucleic acids, metabolites, or other substances. The aim of collecting and preserving rare biomarkers is to enable accurate and reliable measurement and analysis of these molecules for diagnostic, prognostic, and therapeutic applications.

The main types of rare biomarker specimen collection and stabilization are circulating cell-free DNA (ccFDNA), circulating tumor cells (CTCs), exosomes, or extracellular vesicles. Circulating cell-free DNA (CCFDNA) includes DNA fragments that are freely circulating in the bloodstream and can originate from both healthy and diseased cells. These fragments carry genetic information and can be analyzed for various diagnostic purposes, such as detecting cancer or monitoring treatment effectiveness. It uses various specimens, such as Serum or plasma and others for several applications including non-invasive prenatal testing (NIPT), oncology, transcriptomics, pharmacogenomics, transplant rejection, population screening, cardiovascular diseases, and others. These are used by various end-users, such as hospitals, perinatal clinics, public health labs, private or commercial labs, physician labs, research institutes, and others.

Rare Biomarkers Specimen Collection And Stabilization Market Size and growth rate 2025 to 2029: Graph

What Is The Rare Biomarkers Specimen Collection And Stabilization Market Size 2025 And Growth Rate?

The rare biomarkers specimen collection and stabilization market size has grown rapidly in recent years. It will grow from $32.01 billion in 2024 to $35.29 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to the human genome project, increase in cancer research, pharmaceutical R&D investment, growth of genomics and proteomics, and improved data management and bioinformatics.

What Is The Rare Biomarkers Specimen Collection And Stabilization Market Growth Forecast?

The rare biomarkers specimen collection and stabilization market size is expected to see rapid growth in the next few years. It will grow to $51.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to the expansion of liquid biopsy applications, consumer awareness and demand, increasing adoption of non-invasive techniques, and biomarker discovery in rare diseases. Major trends in the forecast period include advancements in preservation technology, growth in genomic and proteomic research, the emergence of point-of-care testing, and regulatory advancements and standardization, enhanced data analytics, and AI integration.

The forecast of 9.8% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. labs by restricting access to cryopreservation tubes and stabilizing reagents imported from Denmark and China, potentially compromising rare disease research and increasing biobanking costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Rare Biomarkers Specimen Collection And Stabilization Market Segmented?

1) By Type: Circulating Cell Free Deoxyribonucleic Acid (CCFDNA), Circulating Tumor Cells (CTCs), Exosomes or Extracellular Vesicles

2) By Specimen: Serum Or Plasma, Other Specimens

3) By Application: Non-Invasive Prenatal Testing (NIPT), Oncology, Transcriptomics, Pharmacogenomics, Transplant Rejection, Population Screening, Cardiovascular Diseases, Other Applications

4) By End-User: Hospitals, Perinatal Clinics, Public Health Labs, Private Or Commercial Labs, Physician Labs, Research Institutes, Other End-Users

Subsegments:

1) By Circulating Cell Free Deoxyribonucleic Acid (CCFDNA): Plasma CCFDNA, Serum CCFDNA

2) By Circulating Tumor Cells (CTCs): CTCs In Blood, CTCs In Bone Marrow

3) By Exosomes Or Extracellular Vesicles: Exosomes From Plasma, Exosomes From Serum

What Is Driving The Rare Biomarkers Specimen Collection And Stabilization Market? Increasing Prevalence Of Cancer Is Driving The Growth Of The Rare Bio Markers Specimen Collection And Stabilization

The increasing prevalence of cancer is expected to propel the growth of the rare biomarker specimen collection and stabilization market going forward. Cancer is a group of diseases defined by the uncontrolled proliferation and spread of abnormal cells. The prevalence of cancer is rising owing to environmental pollutants and lifestyle factors, such as smoking and poor diet choices, exacerbating genetic predispositions. The utilization of rare biomarker specimen collection and stabilization methods in cancer prevalence studies facilitates more accurate detection and monitoring of specific cancer types, enhancing diagnostic and therapeutic approaches. For instance, in October 2023, according to a report by the European Commission, a Europe-based governing body, new cancer cases rose to 2.74 million in 2022, indicating a 2.3% increase from 2020. Therefore, the increasing prevalence of cancer is driving the growth of the rare biomarker specimen collection and stabilization market.

Who Are The Major Players In The Global Rare Biomarkers Specimen Collection And Stabilization Market?

Major companies operating in the rare biomarkers specimen collection and stabilization market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Miltenyi Biotec GmbH, Natera Inc., Promega Corporation, Myriad Genetics, Hamilton Company, OraSure Technologies Inc., Fluidigm Corporation, Streck Inc., SeraCare, Enzo Biochem Inc., Epigenomics AG, Veridex LLC

What Are The Key Trends Of The Global Rare Biomarkers Specimen Collection And Stabilization Market? Innovative Automated Pre-Analytical Platform Revolutionizes Biomarker Specimen Collection And Stabilization

Major companies operating in the rare biomarker specimen collection and stabilization market are focusing on developing innovative solutions, such as a pre-analytical platform to automate the preparation of plasma and cell samples for multiomic liquid biopsy. Pre-analytical platform provides consistent, automated fresh sample preparation at the time of blood collection. It allows for complete walk-away processing of whole blood without the need for special tubes or skilled professionals, therefore preserving sample integrity. For instance, in May 2022, Tethis S.p.A., an Italy-based biotechnology company, launched See.d, the first fully automated, standardized pre-analytical platform that offers unique features such as precise sample handling, efficient separation of plasma for cellular fractions, and fixation of white blood cells on SmartBioSurface slides. The platform features a quality control scoring system for objectively evaluating sample stability. This approach enables the systematic scoring of proteomics and metabolomics data sets to determine the stability of plasma and serum samples.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Rare Biomarkers Specimen Collection And Stabilization Market? DiaSorin Bolsters Diagnostic Capabilities Through Acquisition Of Luminex Corporation

In October 2022, DiaSorin, an Italy-based biotechnology company, acquired Luminex Corporation for an undisclosed amount. Through this acquisition, DiaSorin looks forward to leveraging multiplexing technology and Luminex's portfolio to strengthen its existing offerings. With this acquisition, DiaSorin aims to enhance its diagnostic testing capabilities, expand its market presence, and drive innovation in the molecular and immunodiagnostics sectors. Luminex Corporation is a US-based provider of proprietary biological testing instruments that involve rare biomarker specimen collection and stabilization.

What Is The Regional Outlook For The Global Rare Biomarkers Specimen Collection And Stabilization Market?

North America was the largest region in the rare biomarkers specimen collection and stabilization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Rare Biomarkers Specimen Collection And Stabilization Market?

The rare biomarkers specimen collection and stabilization market consists of revenues earned by entities by providing services such as sample collection, stabilization and preservation, customized collection protocols, bio banking and storage and data management and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The rare biomarkers specimen collection and stabilization market also includes sales of biomarker collection kits, laboratory equipment, training and educational materials, quality control materials, and sample storage containers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Rare Biomarkers Specimen Collection And Stabilization Industry?

The rare biomarkers specimen collection and stabilization market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the rare biomarkers specimen collection and stabilization industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Rare Biomarkers Specimen Collection And Stabilization Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $35.29 billion
Revenue Forecast In 2034 $51.22 billion
Growth Rate CAGR of 9.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Circulating Cell Free Deoxyribonucleic Acid (CCFDNA), Circulating Tumor Cells (CTCs), Exosomes or Extracellular Vesicles
2) By Specimen: Serum Or Plasma, Other Specimens
3) By Application: Non-Invasive Prenatal Testing (NIPT), Oncology, Transcriptomics, Pharmacogenomics, Transplant Rejection, Population Screening, Cardiovascular Diseases, Other Applications
4) By End-User: Hospitals, Perinatal Clinics, Public Health Labs, Private Or Commercial Labs, Physician Labs, Research Institutes, Other End-Users Subsegments: 1) By Circulating Cell Free Deoxyribonucleic Acid (CCFDNA): Plasma CCFDNA, Serum CCFDNA
2) By Circulating Tumor Cells (CTCs): CTCs In Blood, CTCs In Bone Marrow
3) By Exosomes Or Extracellular Vesicles: Exosomes From Plasma, Exosomes From Serum
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Miltenyi Biotec GmbH, Natera Inc., Promega Corporation, Myriad Genetics, Hamilton Company, OraSure Technologies Inc., Fluidigm Corporation, Streck Inc., SeraCare, Enzo Biochem Inc., Epigenomics AG, Veridex LLC
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Rare Biomarkers Specimen Collection And Stabilization Market Characteristics

3. Rare Biomarkers Specimen Collection And Stabilization Market Trends And Strategies

4. Rare Biomarkers Specimen Collection And Stabilization Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Rare Biomarkers Specimen Collection And Stabilization Growth Analysis And Strategic Analysis Framework

5.1. Global Rare Biomarkers Specimen Collection And Stabilization PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Rare Biomarkers Specimen Collection And Stabilization Market Growth Rate Analysis

5.4. Global Rare Biomarkers Specimen Collection And Stabilization Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Rare Biomarkers Specimen Collection And Stabilization Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Rare Biomarkers Specimen Collection And Stabilization Total Addressable Market (TAM)

6. Rare Biomarkers Specimen Collection And Stabilization Market Segmentation

6.1. Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Circulating Cell Free Deoxyribonucleic Acid (CCFDNA)

Circulating Tumor Cells (CTCs)

Exosomes Or Extracellular Vesicles

6.2. Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Serum Or Plasma

Other Specimens

6.3. Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Non-Invasive Prenatal Testing (NIPT)

Oncology

Transcriptomics

Pharmacogenomics

Transplant Rejection

Population Screening

Cardiovascular Diseases

Other Applications

6.4. Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Perinatal Clinics

Public Health Labs

Private Or Commercial Labs

Physician Labs

Research Institutes

Other End-Users

6.5. Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Circulating Cell Free Deoxyribonucleic Acid (CCFDNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Plasma CCFDNA

Serum CCFDNA

6.6. Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Circulating Tumor Cells (CTCs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

CTCs In Blood

CTCs In Bone Marrow

6.7. Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Exosomes or Extracellular Vesicles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Exosomes From Plasma

Exosomes From Serum

7. Rare Biomarkers Specimen Collection And Stabilization Market Regional And Country Analysis

7.1. Global Rare Biomarkers Specimen Collection And Stabilization Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Rare Biomarkers Specimen Collection And Stabilization Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market

8.1. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Rare Biomarkers Specimen Collection And Stabilization Market

9.1. China Rare Biomarkers Specimen Collection And Stabilization Market Overview

9.2. China Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Rare Biomarkers Specimen Collection And Stabilization Market

10.1. India Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Rare Biomarkers Specimen Collection And Stabilization Market

11.1. Japan Rare Biomarkers Specimen Collection And Stabilization Market Overview

11.2. Japan Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Rare Biomarkers Specimen Collection And Stabilization Market

12.1. Australia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Rare Biomarkers Specimen Collection And Stabilization Market

13.1. Indonesia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Rare Biomarkers Specimen Collection And Stabilization Market

14.1. South Korea Rare Biomarkers Specimen Collection And Stabilization Market Overview

14.2. South Korea Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market

15.1. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market Overview

15.2. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Rare Biomarkers Specimen Collection And Stabilization Market

16.1. UK Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Rare Biomarkers Specimen Collection And Stabilization Market

17.1. Germany Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Rare Biomarkers Specimen Collection And Stabilization Market

18.1. France Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Rare Biomarkers Specimen Collection And Stabilization Market

19.1. Italy Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Rare Biomarkers Specimen Collection And Stabilization Market

20.1. Spain Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market

21.1. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market Overview

21.2. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Rare Biomarkers Specimen Collection And Stabilization Market

22.1. Russia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Rare Biomarkers Specimen Collection And Stabilization Market

23.1. North America Rare Biomarkers Specimen Collection And Stabilization Market Overview

23.2. North America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Rare Biomarkers Specimen Collection And Stabilization Market

24.1. USA Rare Biomarkers Specimen Collection And Stabilization Market Overview

24.2. USA Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Rare Biomarkers Specimen Collection And Stabilization Market

25.1. Canada Rare Biomarkers Specimen Collection And Stabilization Market Overview

25.2. Canada Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Rare Biomarkers Specimen Collection And Stabilization Market

26.1. South America Rare Biomarkers Specimen Collection And Stabilization Market Overview

26.2. South America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Rare Biomarkers Specimen Collection And Stabilization Market

27.1. Brazil Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Rare Biomarkers Specimen Collection And Stabilization Market

28.1. Middle East Rare Biomarkers Specimen Collection And Stabilization Market Overview

28.2. Middle East Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Rare Biomarkers Specimen Collection And Stabilization Market

29.1. Africa Rare Biomarkers Specimen Collection And Stabilization Market Overview

29.2. Africa Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Rare Biomarkers Specimen Collection And Stabilization Market Competitive Landscape And Company Profiles

30.1. Rare Biomarkers Specimen Collection And Stabilization Market Competitive Landscape

30.2. Rare Biomarkers Specimen Collection And Stabilization Market Company Profiles

30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Rare Biomarkers Specimen Collection And Stabilization Market Other Major And Innovative Companies

31.1. Eurofins Scientific SE

31.2. Agilent Technologies Inc.

31.3. PerkinElmer Inc.

31.4. Illumina Inc.

31.5. Charles River Laboratories International Inc.

31.6. Bio-Rad Laboratories Inc.

31.7. Bruker Corporation

31.8. QIAGEN N.V.

31.9. Miltenyi Biotec GmbH

31.10. Natera Inc.

31.11. Promega Corporation

31.12. Myriad Genetics

31.13. Hamilton Company

31.14. OraSure Technologies Inc.

31.15. Fluidigm Corporation

32. Global Rare Biomarkers Specimen Collection And Stabilization Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rare Biomarkers Specimen Collection And Stabilization Market

34. Recent Developments In The Rare Biomarkers Specimen Collection And Stabilization Market

35. Rare Biomarkers Specimen Collection And Stabilization Market High Potential Countries, Segments and Strategies

35.1 Rare Biomarkers Specimen Collection And Stabilization Market In 2029 - Countries Offering Most New Opportunities

35.2 Rare Biomarkers Specimen Collection And Stabilization Market In 2029 - Segments Offering Most New Opportunities

35.3 Rare Biomarkers Specimen Collection And Stabilization Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Circulating Cell Free Deoxyribonucleic Acid (CCFDNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Circulating Tumor Cells (CTCs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Exosomes or Extracellular Vesicles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Rare Biomarkers Specimen Collection And Stabilization Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Rare Biomarkers Specimen Collection And Stabilization Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: F. Hoffmann-La Roche AG Financial Performance
  • Table 79: Thermo Fisher Scientific Inc. Financial Performance
  • Table 80: Abbott Laboratories Financial Performance
  • Table 81: Merck KGaA Financial Performance
  • Table 82: Becton Dickinson and Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Circulating Cell Free Deoxyribonucleic Acid (CCFDNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Circulating Tumor Cells (CTCs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Exosomes or Extracellular Vesicles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Rare Biomarkers Specimen Collection And Stabilization Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Rare Biomarkers Specimen Collection And Stabilization Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: F. Hoffmann-La Roche AG Financial Performance
  • Figure 79: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 80: Abbott Laboratories Financial Performance
  • Figure 81: Merck KGaA Financial Performance
  • Figure 82: Becton Dickinson and Company Financial Performance

Strong CAGR to Propel in the Central Nervous System Lymphoma Treatment Market and Beyond upto $1.66 Billion by 2029

Read More About Strong CAGR to Propel in the Central Nervous System Lymphoma Treatment Market and Beyond upto $1.66 Billion by 2029

Cerebral Adrenoleukodystrophy (CALD) Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Read More About Cerebral Adrenoleukodystrophy (CALD) Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Cerebral Amyloid Angiopathy Treatment Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Read More About Cerebral Amyloid Angiopathy Treatment Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Chikungunya Market Trends: Regional Breakdowns and Strategic Insights

Read More About Global Chikungunya Market Trends: Regional Breakdowns and Strategic Insights

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Read More About Review key data-driven trends shaping the global data storage market in 2025.

Food Display Cabinet Global Market Report 2025 – By Type (Refrigerated Food Display Cabinets, Heated Food Display Cabinets), By Materials (Glass, Stainless Steel, Wood, Plastic), By End User (Supermarket And Hypermarket,...

View Report

Epoxy Composite Global Market Report 2025 – By Fiber Type (Glass Fiber, Carbon Fiber, Other Fiber Types), By Manufacturing Process (Lay-up, Compression Molding, Resin Injection, Resin Transfer Molding, Filament Winding, ...

View Report

Orthopedic Surgical Robots Global Market Report 2025 – By Product (Robotic System, Robotic Accessories, Software And Services), By Application (Partial Knee Replacement, Total Knee Replacement, Minimally Invasive Surgery...

View Report

Air-Dried Food Global Market Report 2025 – By Product (Fruits And Vegetables, Herbs And Spices, Meat And Seafood, Other Products), By Form (Powder, Granules, Flakes), By Technique (Hot-Air Dried Food, Freeze Dried Food),...

View Report

Biomedical Textiles Global Market Report 2025 – By Product Type (Non Implantable, Implantable), By Fabric (Non-Woven Biomedical Textiles, Woven Biomedical Textiles, Knitted Biomedical Textiles), By Fiber Type (Non Biodeg...

View Report

Organic Edible Nuts And Seeds Global Market Report 2025 – By Product (Nuts, Seeds), By Distribution Channel (Business To Business (B2B), Business To Consumer (B2C)), By Application (Bakery And Confectionery, Beverages, C...

View Report

Content Delivery Network Global Market Report 2025 – By Content Type (Static Content, Dynamic Content), By Component (Solution, Services), By Provider Type (Traditional CDN, Cloud CDN, P2P CDN, Telecom CDN), By End-User ...

View Report

Frequently Asked Questions

Rare biomarkers specimen collection and stabilization refers to the process of collecting and preserving biological samples containing rare or low-abundance molecules that serve as indications of specific biological processes, diseases, or situations. These biomarkers could be specific proteins, nucleic acids, metabolites, or other substances. The aim of collecting and preserving rare biomarkers is to enable accurate and reliable measurement and analysis of these molecules for diagnostic, prognostic, and therapeutic applications. For further insights on this market, request a sample here

The market major growth driver - Increasing Prevalence Of Cancer Is Driving The Growth Of The Rare Bio Markers Specimen Collection And Stabilization. For further insights on this market, request a sample here

The rare biomarkers specimen collection and stabilization market size has grown rapidly in recent years. It will grow from $32.01 billion in 2024 to $35.29 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to the human genome project, increase in cancer research, pharmaceutical R&D investment, growth of genomics and proteomics, and improved data management and bioinformatics. The rare biomarkers specimen collection and stabilization market size is expected to see strong growth in the next few years. It will grow to " $51.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to the expansion of liquid biopsy applications, consumer awareness and demand, increasing adoption of non-invasive techniques, and biomarker discovery in rare diseases. Major trends in the forecast period include advancements in preservation technology, growth in genomic and proteomic research, the emergence of point-of-care testing, and regulatory advancements and standardization, enhanced data analytics, and AI integration. For further insights on this market, request a sample here

The rare biomarkers specimen collection and stabilizationmarket covered in this report is segmented –
1) By Type: Circulating Cell Free Deoxyribonucleic Acid (CCFDNA); Circulating Tumor Cells (CTCs); Exosomes or Extracellular Vesicles
2) By Specimen: Serum Or Plasma; Other Specimens
3) By Application: Non-Invasive Prenatal Testing (NIPT); Oncology; Transcriptomics; Pharmacogenomics; Transplant Rejection; Population Screening; Cardiovascular Diseases; Other Applications
4) By End-User: Hospitals; Perinatal Clinics; Public Health Labs; Private Or Commercial Labs; Physician Labs; Research Institutes; Other End-Users Subsegments:
1) By Circulating Cell Free Deoxyribonucleic Acid (CCFDNA): Plasma CCFDNA; Serum CCFDNA
2) By Circulating Tumor Cells (CTCs): CTCs In Blood; CTCs In Bone Marrow
3) By Exosomes Or Extracellular Vesicles: Exosomes From Plasma; Exosomes From Serum For further insights on this market, request a sample here

North America was the largest region in the rare biomarkers specimen collection and stabilization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare biomarkers specimen collection and stabilization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the rare biomarkers specimen collection and stabilization market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Miltenyi Biotec GmbH, Natera Inc., Promega Corporation, Myriad Genetics, Hamilton Company, OraSure Technologies Inc., Fluidigm Corporation, Streck Inc., SeraCare, Enzo Biochem Inc., Epigenomics AG, Veridex LLC . For further insights on this market, request a sample here.

Major trends in this market include Innovative Automated Pre-Analytical Platform Revolutionizes Biomarker Specimen Collection And Stabilization. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Rare Biomarkers Specimen Collection And Stabilization Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon